Related Information
This guide provides HCPs with an overview of NovoSecure™, a support program designed to assist your patients throughout the reimbursement process.
Novoeight® (antihemophilic factor, recombinant) is indicated for use in adults and children with hemophilia A for on-demand treatment and control of bleeding episodes, perioperative management, and routine prophylaxis to reduce the frequency of bleeding episodes.